Transcatheter Interventions for Tricuspid Insufficiency in Italy

Launched by MARIANNA ADAMO · Jan 30, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how well a specific heart procedure called transcatheter tricuspid valve intervention works for patients with tricuspid valve insufficiency, a condition where the heart's valve doesn't close properly, leading to blood flow issues. Researchers are collecting information from hospitals in Italy about patients who have had this procedure, looking at their health before and after the treatment to see how effective it is and what outcomes they experience over time.

To participate in the trial, patients need to have tricuspid regurgitation, which can occur in people who have either never had surgery on this valve or have had some type of valve repair before. Eligible participants should be able to give their consent to join the study and attend follow-up appointments. The study is open to all adults aged between 65 and 75, and it aims to gather real-world data to help improve future treatments for this heart condition. If you or a loved one are considering this procedure, this study may provide valuable insights into the benefits and risks involved.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients undergoing transcatheter treatment of tricuspid regurgitation (native valve -with or without previous surgical valve repair - or degenerated bioprosthesis)
• • 2. Patients who are willing and capable of providing informed consent, and participating in all follow-ups associated with this clinical investigation.
• Exclusion Criteria:
• • 1. Valve anatomy unsuitable for transcatheter tricuspid valve interventions.
• • 2. Subjects who are unable or not willing to complete follow-up visits and examination for the duration of the study.